Previous close | 0.2000 |
Open | 0.0100 |
Bid | 0.0000 |
Ask | 5.0000 |
Strike | 55.00 |
Expiry date | 2024-05-17 |
Day's range | 0.0100 - 0.0500 |
Contract range | N/A |
Volume | |
Open interest | 305 |
Review 10x Genomics' (TXG) international revenue performance and how it affects the predictions of financial analysts on Wall Street and the future prospects for the stock.
10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today announced that members of its management team will participate in a fireside chat at the BofA Securities 2024 Healthcare Conference on Tuesday, May 14, at 4:20 p.m. Pacific Time.
10x Genomics ( NASDAQ:TXG ) First Quarter 2024 Results Key Financial Results Revenue: US$141.0m (up 5.0% from 1Q 2023...